Aunt Minnie, the largest and most comprehensive community web site for medical imaging professionals worldwide, has published a story about Optellum's FDA clearance. Read...

Virtual Nodule Clinic empowers clinicians to make optimal clinical decisions in early-stage lung cancer diagnosis and is now commercially available in the United States....

Healthcare UK, part of the Department for International Trade (DIT), has launched a programme to showcase the UK's leading digital health companies.  Digital Health and Artificial Intelligence is seen as the answer to...

2020 was an extraordinary year and, looking back, while it was dominated by the world health crisis of the pandemic there were also colossal...

In recent months, three new appointments have expanded the Optellum team to grow commercial adoption of the Optellum Virtual Nodule Clinic software in the USA....

Business Insider highlights Optellum amongst top healthcare start-ups that are heating up and set to take off in 2021. Business Insider interviewed dozens of venture capitalists and...

Dr Vachani presented a virtual poster as a three-minute video as part of a session that highlighted lung cancer projects across the continuum of...

Optellum is proud to be a key industry partner in a £11M University of Oxford-led AI programme to accelerate lung cancer diagnosis. NHS England...

Global leading doctors from Vanderbilt and Oxford have published independent clinical validation of the Optellum Lung Cancer Prediction AI, illustrating its potential to shorten...

The Optellum artificial intelligence prediction model has been demonstrated to outperform the best currently used model. Prediction of the likelihood of malignancy is central...

Optellum has strengthened leadership team to support the commercialisation and clinical validation of its first product, and the development of product pipeline in the...

Optellum Chairman & co-founder, Prof. Sir Michael Brady FRS (center), is named the founding Board of Trustees member, and the interim President of the...

Optellum Founder and Chief Science & Technology Officer will share the lessons learned by Optellum in enabling early lung cancer diagnosis & treatment at...

IASLC World Conference on Lung Cancer, the world's premier event for physicians and scientists advancing the fight against world's deadliest cancer, is taking place...

The Optellum team is excited to be selected for the 2019 Digital Health Accelerator Cohort at TMCx, to be spend 4 months building our...

Optellum team and advisors took the lead role in preparing the winning bid, with Optellum Chairman,  Prof Sir Michael Brady FRS named the Executive...

This week Optellum has been highlighted in three presentations at the IASLC World Conference on Lung Cancer in Toronto, Canada. On Tuesday, Dr. Peter...

Optellum welcomes an internationally renowned physician and scientist in early lung cancer diagnosis and treatment,  Dr. Sam Janes MD, to join its Medical Advisory Board....

Join us at the American Thoracic Society 2018 Congress in San Diego,  North America's premier congress for pulmonary medicine, from May 20 till May...

Optellum is delighted to welcome Dr. Christine Berg, the co-Principal Investigator of the US National Lung Screening Trial (NLST), the biggest ever randomized clinical...

Optellum Scientific Advisory Board welcomes Leo Grady,  an internationally recognized expert in healthcare machine learning and building medical imaging Software-as-a-Service (SaaS) products. Leo Grady,...

The government's healthcare tsar, Sir John Bell, has told BBC News that AI could "save the NHS".  Sir Bell, the Regius Professor of Medicine,...

Optellum welcomes one of world's most visionary and influential thought leaders in lung cancer screening, Dr. Matthijs Oudkerk, to join its Medical Advisory Board....

EIT Health LUCINDA (Early Lung Cancer Diagnosis with Artificial Intelligence and Big Data) is a consortium of leading clinicians & hospitals in the UK,...